It is known that D-dimer and fibrinogen levels increase, and prothrombin time (PT) and activated prothrombin time (aPTT) are prolonged in patients with a high risk of arterial and venous thrombus due to COVID-19 [20]. The gene discussed is F2; the disease is COVID-19.